Related Experiment Video
Updated: Aug 16, 2026

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
Published on: January 9, 2020
Millennium Pharma Summit--strategic planning to increase growth and generate pharmaceutical shareholder value. 26-27
1Current Drugs Ltd, 34-42 Cleveland Street, London, W1P 6LB, UK. charlotte@cursci.co.uk
Abstract:
With mergers and acquisitions (M&As) being the 'watch words' of the moment among those involved in the pharmaceutical industry, this meeting aimed to bring together the senior hierarchy of both medium and big pharma to discuss the issues pertinent to competitive survival and shareholder profit delivery. Along with a more objective analysis delivered by a number of management consultancy representatives, the summit presented delegates with interesting and often controversial viewpoints on: strategic partnerships and alliances; developing organizational models to generate profitability; the promotion of innovative R&D to maximize shareholder value; the development of marketing strategies in line with increasing consumer power; and, past, present and future consequences for the industry as a result of 'merger mania'.
More Related Videos
Related Concept Videos
Production of Pharmaceuticals
Preclinical Development: Overview
Clinical Trials: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacogenomics: Identification of New Drug Targets
Scale-Up Processes

